MeSH term
Frequency | Condition_Probility | Adult | 3 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 8 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Humans | 182 | 0.0 |
Middle Aged | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 201 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 12 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
Animals | 174 | 0.0 |
Apoptosis | 12 | 0.0 |
Cells, Cultured | 32 | 0.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
*Gene Expression Regulation | 22 | 1.0 |
*Heat | 18 | 16.0 |
Heat-Shock Proteins/*biosynthesis/genetics/metabolism | 3 | 75.0 |
*Heat-Shock Response | 15 | 71.0 |
In Vitro | 10 | 0.0 |
Mice | 72 | 0.0 |
Organ Specificity | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 115 | 0.0 |
Buthionine Sulfoximine/pharmacology | 2 | 5.0 |
Cause of Death | 2 | 1.0 |
DNA/*metabolism | 6 | 1.0 |
DNA-Binding Proteins/*metabolism/physiology | 2 | 5.0 |
Female | 25 | 0.0 |
Heat | 64 | 12.0 |
Heat-Shock Proteins/genetics | 2 | 11.0 |
Male | 55 | 0.0 |
Myocardium/*metabolism | 6 | 2.0 |
Oxidation-Reduction | 8 | 0.0 |
Rats | 46 | 0.0 |
Blotting, Western | 37 | 0.0 |
DNA-Binding Proteins/metabolism | 28 | 1.0 |
Disease Models, Animal | 6 | 0.0 |
Dose-Response Relationship, Drug | 17 | 0.0 |
Heat-Shock Proteins/*metabolism | 18 | 31.0 |
Heat-Shock Proteins 70/metabolism | 9 | 17.0 |
Immunohistochemistry | 7 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Quinones/*pharmacology | 4 | 12.0 |
Trans-Activation (Genetics)/drug effects | 3 | 1.0 |
Analysis of Variance | 3 | 0.0 |
Blotting, Northern | 15 | 0.0 |
Comparative Study | 27 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 26 | 2.0 |
Electrophoretic Mobility Shift Assay | 5 | 1.0 |
Heat-Shock Proteins 70/genetics/*metabolism | 3 | 18.0 |
Kinetics | 25 | 0.0 |
RNA, Messenger/*metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 39 | 0.0 |
Gene Expression Regulation/*physiology | 6 | 1.0 |
Heat-Shock Proteins 70/*genetics/metabolism | 7 | 70.0 |
Heat-Shock Response/*genetics | 5 | 83.0 |
Phosphorylation | 46 | 0.0 |
RNA, Messenger/metabolism | 14 | 0.0 |
Trans-Activation (Genetics)/physiology | 2 | 2.0 |
Tumor Cells, Cultured | 30 | 0.0 |
Cell Line | 36 | 0.0 |
DNA-Binding Proteins/biosynthesis/*metabolism | 3 | 4.0 |
Drug Combinations | 2 | 0.0 |
Embryo | 2 | 0.0 |
Fibroblasts | 5 | 0.0 |
Gene Expression Regulation/physiology | 3 | 1.0 |
RNA, Messenger/biosynthesis | 11 | 0.0 |
Time Factors | 25 | 0.0 |
Body Temperature | 2 | 2.0 |
Cell Nucleus/chemistry | 5 | 2.0 |
Cytoplasm/chemistry | 4 | 2.0 |
DNA-Binding Proteins/analysis/metabolism | 2 | 9.0 |
Isoquinolines/pharmacology | 2 | 1.0 |
Rats, Sprague-Dawley | 13 | 0.0 |
Sulfonamides/pharmacology | 2 | 1.0 |
Heat-Shock Proteins 70/*genetics | 17 | 34.0 |
Heat-Shock Proteins 90/*genetics | 2 | 40.0 |
Species Specificity | 4 | 0.0 |
Temperature | 24 | 2.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Heat-Shock Proteins 70/biosynthesis/*genetics | 3 | 60.0 |
Binding Sites/genetics | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 8 | 1.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
Heat-Shock Proteins/*genetics/metabolism | 7 | 53.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Stress/*genetics/metabolism | 4 | 100.0 |
Gene Expression Regulation | 19 | 0.0 |
Genes, Reporter | 11 | 0.0 |
Heat-Shock Proteins 70/biosynthesis/genetics | 4 | 66.0 |
Heat-Shock Response | 4 | 23.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Promoter Regions (Genetics) | 22 | 0.0 |
Response Elements | 2 | 0.0 |
Sodium Salicylate/pharmacology | 4 | 28.0 |
Transcription, Genetic | 32 | 0.0 |
Cell Survival | 11 | 0.0 |
Flow Cytometry | 7 | 0.0 |
Heat-Shock Proteins/*biosynthesis | 9 | 47.0 |
K562 Cells | 12 | 2.0 |
Models, Biological | 7 | 0.0 |
PC12 Cells | 2 | 0.0 |
Up-Regulation | 7 | 0.0 |
Base Sequence | 44 | 0.0 |
Cysteine/chemistry/metabolism | 2 | 40.0 |
DNA Primers | 11 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 5 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 11 | 0.0 |
Hela Cells | 63 | 1.0 |
Mutagenesis, Site-Directed | 13 | 0.0 |
Protein Conformation | 13 | 0.0 |
Calcium/*metabolism | 2 | 0.0 |
Cell Nucleus/metabolism | 20 | 1.0 |
Cycloheximide/pharmacology | 8 | 1.0 |
Cytosol/metabolism | 3 | 0.0 |
Dactinomycin/pharmacology | 2 | 0.0 |
Enzyme Inhibitors/*pharmacology | 3 | 0.0 |
Indoles/pharmacology | 2 | 0.0 |
Maleimides/pharmacology | 2 | 2.0 |
Nitric Oxide/metabolism | 3 | 1.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
RNA, Messenger/analysis | 14 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Cell Line, Tumor | 6 | 0.0 |
Cell Proliferation | 2 | 1.0 |
Cytoplasm/metabolism | 6 | 0.0 |
DNA-Binding Proteins/*metabolism | 42 | 2.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Protein Binding | 27 | 0.0 |
Protein Biosynthesis | 8 | 0.0 |
Trans-Activation (Genetics) | 17 | 1.0 |
Transfection | 37 | 0.0 |
Cell Death | 2 | 0.0 |
Cell Line, Transformed | 3 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 7 | 3.0 |
Heat-Shock Proteins/genetics/*physiology | 7 | 70.0 |
Mitosis | 2 | 0.0 |
Mutation | 10 | 0.0 |
Transcription Factors/genetics/*physiology | 4 | 2.0 |
Binding Sites | 14 | 0.0 |
CHO Cells | 8 | 0.0 |
Cell Nucleus/*metabolism | 4 | 0.0 |
Hamsters | 9 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Dose-Response Relationship, Radiation | 4 | 1.0 |
Enzyme Inhibitors/pharmacology | 13 | 0.0 |
Apoptosis/physiology | 3 | 0.0 |
Enzyme Activation | 9 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 5 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 4 | 0.0 |
DNA-Binding Proteins/*genetics/*metabolism | 4 | 2.0 |
Fibroblasts/cytology | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Heat-Shock Proteins/genetics/metabolism | 8 | 50.0 |
Heat-Shock Proteins 70/genetics/metabolism | 12 | 66.0 |
Molecular Chaperones/metabolism | 2 | 4.0 |
Acclimatization | 2 | 20.0 |
Cold | 2 | 1.0 |
DNA/metabolism | 24 | 1.0 |
Heat-Shock Proteins 70/biosynthesis | 5 | 62.0 |
Carrageenan | 3 | 37.0 |
Cyclooxygenase Inhibitors/pharmacology | 2 | 2.0 |
Indomethacin/pharmacology | 3 | 1.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Pleurisy/chemically induced/*metabolism | 2 | 66.0 |
Rats, Wistar | 10 | 0.0 |
Amino Acid Sequence | 30 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Molecular Sequence Data | 56 | 0.0 |
Protein Folding | 3 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Repetitive Sequences, Amino Acid | 2 | 1.0 |
Structure-Activity Relationship | 4 | 0.0 |
3T3 Cells | 10 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
Dimerization | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 6 | 0.0 |
Heat-Shock Proteins/biosynthesis | 4 | 50.0 |
Heat-Shock Proteins 90/metabolism | 3 | 10.0 |
Luciferases/metabolism | 4 | 0.0 |
Recombinant Proteins/metabolism | 8 | 0.0 |
Stress | 5 | 9.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Amino Acid Substitution | 5 | 0.0 |
Chick Embryo | 4 | 0.0 |
Dogs | 2 | 0.0 |
Phenotype | 4 | 0.0 |
Protein Structure, Tertiary | 9 | 0.0 |
Cysteine Endopeptidases/metabolism | 4 | 1.0 |
DNA-Binding Proteins/chemistry/*metabolism | 5 | 2.0 |
Enzyme Activation/drug effects | 4 | 0.0 |
Imidazoles/pharmacology | 2 | 0.0 |
Leupeptins/pharmacology | 4 | 3.0 |
Mitogen-Activated Protein Kinase 9 | 2 | 6.0 |
Multienzyme Complexes/antagonists & inhibitors/metabolism | 3 | 13.0 |
Proteasome Endopeptidase Complex | 10 | 1.0 |
Pyridines/pharmacology | 2 | 0.0 |
Rabbits | 5 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 5 | 1.0 |
Signal Transduction/drug effects | 2 | 0.0 |
*Trans-Activation (Genetics)/drug effects | 2 | 4.0 |
Cell Compartmentation | 3 | 0.0 |
DNA-Binding Proteins/genetics/isolation & purification/*metabolism | 2 | 6.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Protein Transport | 2 | 0.0 |
Heat Stress Disorders/*metabolism | 2 | 100.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
DNA-Binding Proteins/physiology | 7 | 2.0 |
Diterpenes/*pharmacology | 2 | 6.0 |
Heat-Shock Proteins 70/*biosynthesis | 8 | 53.0 |
Mitogen-Activated Protein Kinases/metabolism | 6 | 0.0 |
Oxidants/*pharmacology | 2 | 8.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics | 3 | 1.0 |
DNA-Binding Proteins/*antagonists & inhibitors | 2 | 11.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Glucocorticoids/pharmacology | 2 | 1.0 |
Point Mutation | 7 | 0.0 |
Signal Transduction | 6 | 0.0 |
Cell Hypoxia/drug effects | 2 | 33.0 |
DNA-Binding Proteins/*biosynthesis | 3 | 2.0 |
L-Lactate Dehydrogenase/metabolism | 3 | 2.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 3 | 0.0 |
Serine/*metabolism | 3 | 3.0 |
Transcription Factors/chemistry/*metabolism | 3 | 2.0 |
Stress, Mechanical | 4 | 1.0 |
Culture Media, Serum-Free | 2 | 0.0 |
Cysteine Endopeptidases/*metabolism | 3 | 1.0 |
Cysteine Proteinase Inhibitors/pharmacology | 4 | 1.0 |
Fibroblasts/*physiology | 2 | 3.0 |
Multienzyme Complexes/*metabolism | 3 | 2.0 |
RNA, Messenger/genetics | 7 | 0.0 |
Gene Expression/drug effects | 3 | 0.0 |
*Avian Proteins | 6 | 6.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Chickens | 5 | 0.0 |
Cloning, Molecular | 19 | 0.0 |
Heat-Shock Proteins/genetics/*metabolism | 10 | 35.0 |
Heat-Shock Proteins 90/genetics/*metabolism | 3 | 60.0 |
Liver/metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
Heat-Shock Proteins/chemistry/genetics/*metabolism | 2 | 50.0 |
Heat-Shock Response/*physiology | 5 | 62.0 |
Phylogeny | 2 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Cadmium Chloride/*pharmacology | 2 | 66.0 |
DNA-Binding Proteins/chemistry/drug effects/*metabolism | 2 | 100.0 |
Tumor Cells, Cultured/metabolism | 2 | 1.0 |
Binding, Competitive | 3 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics/metabolism | 2 | 18.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
Heat-Shock Proteins 70/genetics | 10 | 27.0 |
Immunoblotting | 3 | 0.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Acetylcysteine/pharmacology | 2 | 2.0 |
Arsenites/*pharmacology | 3 | 16.0 |
Flavonoids/pharmacology | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Heat-Shock Proteins 70/*metabolism | 8 | 30.0 |
Anti-Inflammatory Agents, Non-Steroidal/pharmacology | 2 | 2.0 |
Child | 2 | 0.0 |
Heat-Shock Response/drug effects/*physiology | 3 | 100.0 |
Gene Expression/physiology | 3 | 0.0 |
Luciferases/genetics | 4 | 1.0 |
Trans-Activation (Genetics)/*physiology | 2 | 1.0 |
Fibroblasts/cytology/drug effects/metabolism | 3 | 5.0 |
*Antigens, Nuclear | 5 | 3.0 |
*DNA Helicases | 5 | 2.0 |
*Saccharomyces cerevisiae Proteins | 12 | 1.0 |
Heat-Shock Proteins/metabolism | 14 | 24.0 |
Hemodynamic Processes | 2 | 1.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Myocardial Reperfusion | 2 | 11.0 |
DNA-Binding Proteins/genetics | 5 | 0.0 |
Glutathione/metabolism | 5 | 2.0 |
Heat-Shock Proteins/*genetics | 13 | 19.0 |
Mice, Inbred ICR | 2 | 0.0 |
Oxidative Stress/*physiology | 2 | 2.0 |
Plants, Toxic | 2 | 5.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Trans-Activators | 2 | 4.0 |
Crosses, Genetic | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Brain/embryology | 2 | 4.0 |
Protein Isoforms | 3 | 0.0 |
Models, Genetic | 6 | 0.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Regulatory Sequences, Nucleic Acid | 5 | 0.0 |
Trans-Activation (Genetics)/*genetics | 5 | 5.0 |
Trans-Activators/genetics/metabolism | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 5 | 0.0 |
*Gene Expression Regulation/drug effects | 3 | 1.0 |
Heat-Shock Proteins/*physiology | 4 | 33.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/*physiology | 2 | 15.0 |
DNA-Binding Proteins/biosynthesis/genetics/*physiology | 2 | 5.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Mice, Knockout | 10 | 0.0 |
*Heat-Shock Proteins | 3 | 4.0 |
Sequence Deletion | 6 | 0.0 |
DNA-Binding Proteins/*physiology | 8 | 1.0 |
English Abstract | 5 | 0.0 |
Tumor Cells, Cultured/*physiology | 2 | 15.0 |
U937 Cells | 2 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
*Trans-Activation (Genetics) | 8 | 1.0 |
Transcription Factors/*metabolism | 20 | 1.0 |
Glycogen Synthase Kinase 3 | 2 | 2.0 |
Glycogen Synthase Kinases | 2 | 3.0 |
Transcription, Genetic/*drug effects | 3 | 0.0 |
Xenopus laevis | 5 | 1.0 |
Fever/*metabolism | 2 | 40.0 |
Apoptosis/*physiology | 3 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Stress/physiopathology | 2 | 8.0 |
DNA Primers/genetics | 2 | 0.0 |
Gene Expression | 10 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
Mice, Transgenic | 7 | 0.0 |
Myocardium/metabolism | 2 | 0.0 |
Aging/*metabolism | 3 | 1.0 |
Macromolecular Substances | 6 | 0.0 |
Rats, Inbred F344 | 5 | 1.0 |
Transcription Factors/metabolism | 16 | 1.0 |
Ubiquitins/genetics/*metabolism | 2 | 9.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Cyclosporine/*pharmacology | 3 | 2.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 4 | 3.0 |
Indomethacin/*pharmacology | 2 | 5.0 |
Stress/genetics/metabolism | 3 | 27.0 |
Heat-Shock Proteins/*genetics/*metabolism | 4 | 66.0 |
Antioxidants/pharmacology | 2 | 1.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Swine | 3 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*genetics/*physiology | 2 | 5.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Inflammation | 2 | 0.0 |
Stress/*physiopathology | 2 | 6.0 |
Arsenites/pharmacology | 4 | 21.0 |
Azetidinecarboxylic Acid/pharmacology | 2 | 100.0 |
Protein Synthesis Inhibitors/pharmacology | 3 | 0.0 |
Sodium Compounds/pharmacology | 2 | 14.0 |
Sulfhydryl Compounds/metabolism | 2 | 5.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 3 | 2.0 |
*Transcription, Genetic | 12 | 0.0 |
Heating | 2 | 9.0 |
Acetylcysteine/*analogs & derivatives/pharmacology | 3 | 7.0 |
Cysteine Proteinase Inhibitors/*pharmacology | 4 | 13.0 |
Down-Regulation | 3 | 0.0 |
Gene Expression Regulation/drug effects | 7 | 0.0 |
Leupeptins/*pharmacology | 4 | 30.0 |
Heat-Shock Proteins/*biosynthesis/genetics | 4 | 57.0 |
Green Fluorescent Proteins | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Doxorubicin/pharmacology | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Stress/metabolism/*physiopathology | 2 | 40.0 |
Saccharomyces cerevisiae/genetics | 4 | 0.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
DNA-Binding Proteins/analysis/*biosynthesis | 3 | 25.0 |
Biological Transport | 2 | 0.0 |
Cell Nucleus/*metabolism/ultrastructure | 2 | 6.0 |
Chimeric Proteins/chemistry/metabolism | 2 | 3.0 |
Genetic Complementation Test | 3 | 0.0 |
Oncorhynchus mykiss/*metabolism | 3 | 75.0 |
Testis/metabolism | 3 | 1.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
*Apoptosis | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 2 | 1.0 |
Cell Cycle | 3 | 0.0 |
Multigene Family | 2 | 0.0 |
*Oxidative Stress | 2 | 0.0 |
Heat-Shock Response/physiology | 2 | 28.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 2 | 3.0 |
Age Factors | 3 | 0.0 |
Animals, Newborn | 3 | 0.0 |
Catalysis | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 3 | 3.0 |
Genetic Vectors | 2 | 0.0 |
Heat/*adverse effects | 2 | 18.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Leukemia, Erythroblastic, Acute | 5 | 5.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Hemin/*physiology | 2 | 40.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
Hemin/pharmacology | 4 | 20.0 |
Mammals | 4 | 1.0 |
*Ultraviolet Rays | 2 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Gene Expression Regulation, Plant | 2 | 6.0 |
Azetidines/pharmacology | 3 | 42.0 |
Glutathione/*metabolism | 2 | 3.0 |
Glutathione Disulfide/metabolism | 2 | 16.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
Heat-Shock Proteins/physiology | 2 | 22.0 |
Transcription Factors/genetics | 2 | 0.0 |
Heat-Shock Response/genetics/*physiology | 2 | 100.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Cell Aging | 2 | 2.0 |
Heat-Shock Proteins/drug effects/*metabolism | 2 | 100.0 |
Heat-Shock Proteins/chemistry/genetics/*physiology | 2 | 66.0 |
Peptide Mapping | 5 | 1.0 |
Phosphorus Radioisotopes | 2 | 3.0 |
Cell Extracts | 2 | 1.0 |
Chimeric Proteins | 3 | 3.0 |
Fungal Proteins/genetics/metabolism | 2 | 2.0 |
*Nuclear Proteins | 2 | 0.0 |
RNA Splicing | 2 | 0.0 |
DNA, Complementary/genetics | 5 | 0.0 |
Heat-Shock Proteins 70/*biosynthesis/genetics | 4 | 66.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Spermatogenesis/*physiology | 2 | 5.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Gene Targeting | 2 | 0.0 |
Oocytes/*physiology | 2 | 5.0 |
Transcription Factors/biosynthesis/*metabolism | 2 | 4.0 |
Genotype | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
DNA Footprinting | 2 | 0.0 |
Phosphoprotein Phosphatase/*metabolism | 2 | 2.0 |
Heat-Shock Proteins 90/genetics/metabolism | 2 | 50.0 |
Xenopus | 2 | 0.0 |
Transcription Factors/biosynthesis | 3 | 3.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
DNA-Binding Proteins/drug effects/genetics/*metabolism | 2 | 14.0 |
Quercetin/*pharmacology | 2 | 8.0 |
Oligodeoxyribonucleotides | 4 | 0.0 |
Transcription Factors/*biosynthesis | 4 | 3.0 |
Stress/genetics/*metabolism | 2 | 22.0 |
*DNA Repair | 2 | 0.0 |
Nuclear Proteins/*metabolism | 4 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Dithiothreitol/pharmacology | 3 | 3.0 |
Protein Kinases/metabolism | 2 | 0.0 |
Oxidative Stress | 2 | 0.0 |
COS Cells | 5 | 0.0 |
Serine/chemistry | 4 | 2.0 |
Blastocyst | 2 | 16.0 |
Carcinoma, Embryonal | 2 | 13.0 |
*Embryonic and Fetal Development | 2 | 1.0 |
Mice, Inbred Strains | 2 | 0.0 |
Heat-Shock Response/*drug effects | 4 | 100.0 |
Biopolymers | 2 | 1.0 |
Phosphoprotein Phosphatase/antagonists & inhibitors | 2 | 6.0 |
Spermatogenesis/*genetics | 2 | 4.0 |
Transcription Factors/physiology | 2 | 0.0 |
Recombinant Proteins/isolation & purification | 2 | 4.0 |
Mice, Inbred C3H | 2 | 0.0 |
Cadmium/pharmacology | 2 | 8.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Molecular Weight | 4 | 0.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
Gene Expression/*drug effects | 2 | 0.0 |
Guinea Pigs | 2 | 0.0 |
Aging/*physiology | 2 | 0.0 |
DNA-Binding Proteins/metabolism/*physiology | 2 | 1.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
Transcription, Genetic/*genetics | 3 | 1.0 |
*Stress | 2 | 15.0 |
DNA-Binding Proteins/analysis | 2 | 2.0 |
Heat-Shock Proteins/*analysis | 2 | 40.0 |
Heat-Shock Proteins 70/*analysis | 2 | 100.0 |
Transcription Factors/analysis | 2 | 2.0 |
Chromatography, Affinity | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 3 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
*Transcription, Genetic/drug effects | 2 | 1.0 |
Mice, Inbred CBA | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Leucine Zippers/genetics | 2 | 4.0 |
Escherichia coli/genetics | 2 | 0.0 |
Consensus Sequence | 3 | 0.0 |
Oligodeoxyribonucleotides/chemistry | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Chromosomes, Human, Pair 9/genetics | 2 | 1.0 |
Heterochromatin/genetics | 2 | 28.0 |
RNA-Binding Proteins/metabolism | 2 | 2.0 |
Radiation Dosage | 2 | 2.0 |
Gene Expression Profiling | 2 | 0.0 |
Drosophila/genetics | 2 | 1.0 |
Hela Cells/physiology | 2 | 8.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
DNA-Binding Proteins/deficiency/genetics/*physiology | 2 | 8.0 |
Lysine/chemistry | 2 | 2.0 |
